Discussion on: Extended Half-life Versus Standard Half-life Factor Replacement Therapy in Hemophilia A and B: A Systematic Review and Meta-analysis

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title
Extended Half-life Versus Standard Half-life Factor Replacement Therapy in Hemophilia A and B: A Systematic Review and Meta-analysis
Authored by

Kwesi Akonu Adom Mensah Forson
Department of Biology, University of Virginia, Charlottesville, USA.

Obiageri Ihuarulam Okeoma
Department of Medical Laboratory Science, Trinity University Yaba, Lagos, Nigeria.

Oluchi Okechukwu
Department of Laboratory Medicine, University of Vermont Medical Center, VT, USA.

Chidinma Gab-Obinna
Department of Biomedical Science, Kingston University London, UK.

Enobong Edoabasi Obong
Department of Neurology, Washington University, Saint Louis, Missouri, USA.

Richard Afriyie Osei
Department of Nanoscience, University of North Carolina at Greensboro, Greensboro, NC, USA.

Jazuli Isyaku Bala
Department of Hematology and transfusion medicine, Aminu Kano Teaching Hospital (AKTH), Kano, Nigeria.

DOI or Article Link

https://doi.org/10.9734/ijr2h/2026/v9i1215

Leave a Comment